Today: 8 February 2026
Subscribe
Browse Category

Stock Market News 26 December 2025

Micron (MU) Stock Today: AI Memory Demand, Record Guidance, and Fresh Wall Street Targets Drive a Volatile Post‑Christmas Session

Micron (MU) Stock Today: AI Memory Demand, Record Guidance, and Fresh Wall Street Targets Drive a Volatile Post‑Christmas Session

Micron Technology shares traded at $285.37, down 0.46% at 10:42 a.m. ET Friday in light post-Christmas trading. The move follows a record fiscal Q1 report and strong Q2 guidance, with projected revenue of $18.7 billion and non-GAAP EPS of $8.42, both well above analyst estimates. Micron stock has surged about 240% in 2025, driven by AI-related demand and tight memory supply.
26 December 2025
·
Nike Stock (NYSE: NKE) Trades Higher in Holiday Week as Tim Cook Buys Shares; Tariffs and China “Reset” Dominate the 2026 Outlook

Nike Stock (NYSE: NKE) Trades Higher in Holiday Week as Tim Cook Buys Shares; Tariffs and China “Reset” Dominate the 2026 Outlook

Nike shares rose about 1.2% to $60.73 in early Friday trading after Apple CEO Tim Cook bought $3 million in Nike stock, nearly doubling his stake. The purchase follows a sharp drop after Nike’s December 18 earnings, with volume light in the post-holiday market. Cook’s buy was the largest by a Nike director or executive in over a decade, according to Baird.
26 December 2025
·
AI Stocks Today 26.12.2025: Nvidia Rallies on Groq Inference Deal as S&P 500 Hovers Near Records

AI Stocks Today 26.12.2025: Nvidia Rallies on Groq Inference Deal as S&P 500 Hovers Near Records

Nvidia agreed to a non-exclusive license for Groq’s AI inference technology and will hire Groq’s founder Jonathan Ross, President Sunny Madra, and other engineers. The S&P 500 touched an intraday record Friday, nearing 7,000, as AI megacaps led gains in thin post-holiday trading. Financial terms of the Nvidia-Groq deal were not disclosed. Groq will continue operating independently under CEO Simon Edwards.
26 December 2025
···
Wave Life Sciences (WVE) Stock Today: Obesity Drug Catalyst, $402.5M Financing, and What Investors Are Watching Next

Wave Life Sciences (WVE) Stock Today: Obesity Drug Catalyst, $402.5M Financing, and What Investors Are Watching Next

Wave Life Sciences shares fell 0.74% to $18.12 late Thursday morning, underperforming the broader market as biotech stocks slipped. Earlier this month, Wave reported positive Phase 1 data for its obesity drug candidate WVE-007 and raised $402.5 million in an upsized equity offering, extending its cash runway into Q3 2028.
26 December 2025
··
Sunrun Stock (NASDAQ: RUN) News Today: NRG Texas Virtual Power Plant Deal, Tax-Credit Deadline, and Analyst Targets as Markets Rally

Sunrun Stock (NASDAQ: RUN) News Today: NRG Texas Virtual Power Plant Deal, Tax-Credit Deadline, and Analyst Targets as Markets Rally

Sunrun shares traded near $19.78 Friday morning after opening at $20.10, with early volume around 428,000. The company recently announced a Texas partnership with NRG’s Reliant to expand grid services using home batteries. Investors are watching the impact of a looming tax-credit cliff and shifting Federal Reserve rate policy on Sunrun’s financing costs. The S&P 500 hovered near record highs in thin post-holiday trading.
26 December 2025
··
US Stock Market Today (26.12.2025, 10:14 a.m. EST): S&P 500 Nears 7,000 in Thin Post‑Christmas Trade as 2026 Outlook Takes Center Stage

US Stock Market Today (26.12.2025, 10:14 a.m. EST): S&P 500 Nears 7,000 in Thin Post‑Christmas Trade as 2026 Outlook Takes Center Stage

NEW YORK — 26.12.2025 — U.S. stocks were quiet but resilient in mid‑morning trading Friday, with Wall Street largely hovering near record territory as investors leaned into a familiar late‑December script: thin holiday volume, “Santa Claus rally” seasonality, and a growing tug‑of‑war over what 2026 will deliver for rates, earnings, and the AI boom. MarketScreener+1 Market snapshot at 10:14 a.m. EST: flat-to-firm, with record levels still in view By mid‑morning, the major indexes were edging higher by fractions, reflecting more “positioning and patience” than aggressive risk‑taking in the post‑Christmas lull. ETFs tracking the big benchmarks told the same story: minimal
26 December 2025
·
Global Stock Markets Today (26.12.2025): Wall Street Near Record Highs as Asia Advances and Holiday Trading Stays Thin

Global Stock Markets Today (26.12.2025): Wall Street Near Record Highs as Asia Advances and Holiday Trading Stays Thin

Global stocks edged higher Friday in thin post-holiday trading, with the S&P 500 near 6,939 and the Nasdaq at 23,646. Japan’s Nikkei 225 rose 0.7% as the Topix hit a record. Most European markets stayed closed for holidays, focusing activity in the U.S. and Asia. Investors watched for a possible S&P 500 push to 7,000 and tracked expectations for further Fed rate cuts in 2026.
26 December 2025
·
Grupo Aeroméxico (AERO) Stock Today: Latest News, Analyst Targets, Earnings Outlook, and What to Watch Before the NYSE Open

Grupo Aeroméxico (AERO) Stock Today: Latest News, Analyst Targets, Earnings Outlook, and What to Watch Before the NYSE Open

Aeroméxico shares (NYSE: AERO) last closed at $22.18 and indicated higher pre-market at $22.73, following a recent 52-week high of $22.26. The airline returned to public markets on November 6, 2025, with each NYSE ADS representing 10 Mexican shares. Trading remains thin post-holiday, and analysts note increased sensitivity to headlines and regulatory news.
26 December 2025
··
Dow Jones Today (26.12.2025): DJIA Hovers Near 48,700 in Thin Post‑Christmas Trading as Fed-Cut Bets Stay in Focus

Dow Jones Today (26.12.2025): DJIA Hovers Near 48,700 in Thin Post‑Christmas Trading as Fed-Cut Bets Stay in Focus

The Dow Jones Industrial Average hovered near 48,698, down 0.07% in late-morning trading Friday, following a quiet, low-volume session after the Christmas holiday. The index stayed within a narrow range, flat to slightly lower versus Wednesday’s record close. Few major headlines or economic releases shaped the session. Investors looked ahead to next week’s Federal Reserve meeting minutes.
26 December 2025
··
Abivax (ABVX) Stock in Focus: Eli Lilly Takeover Chatter, Obefazimod Phase 3 Momentum, and What to Watch Before the Next U.S. Session

Abivax (ABVX) Stock in Focus: Eli Lilly Takeover Chatter, Obefazimod Phase 3 Momentum, and What to Watch Before the Next U.S. Session

Abivax (NASDAQ: ABVX) rose about 5.3% to $145.31 in premarket trading Friday, with U.S. markets the main venue as Euronext remained closed for St. Stephen’s Day. The stock has surged in December amid Eli Lilly takeover rumors, recent inclusion in the Nasdaq Biotechnology Index, and ongoing interest in its ulcerative colitis drug obefazimod.
26 December 2025
···
POSCO Holdings Stock (NYSE: PKX) in Focus Ahead of the U.S. Open: Louisiana Green-Steel Bet, Lithium Supply Deals, and What Investors Are Watching

POSCO Holdings Stock (NYSE: PKX) in Focus Ahead of the U.S. Open: Louisiana Green-Steel Bet, Lithium Supply Deals, and What Investors Are Watching

POSCO Holdings ADR (NYSE: PKX) traded around $53.50 premarket Friday, down about 2% on light volume ahead of the NYSE open. The move follows POSCO’s disclosure of a $582 million plan to acquire a 20% stake in Hyundai Steel Louisiana LLC, aiming to expand U.S. “green steel” operations. U.S. stock index futures pointed to a flat open amid thin, post-holiday trading.
26 December 2025
·
NVIDIA Stock (NVDA) 26.12.2025: Groq Inference Licensing Deal, Analyst Targets, and What to Watch Before the Next Market Open

NVIDIA Stock (NVDA) 26.12.2025: Groq Inference Licensing Deal, Analyst Targets, and What to Watch Before the Next Market Open

NVIDIA shares traded near $189.89 early Friday after confirming a non-exclusive AI inference technology licensing deal with Groq. Groq remains independent, with key executives joining NVIDIA. Reports cite a potential $20 billion value for the arrangement, though terms remain undisclosed. Trading volumes were thin following the holiday.
26 December 2025
···
Zai Lab Limited Stock (NASDAQ: ZLAB) Today: Pre‑Market Watchlist After China’s COBENFY Approval, NRDL Renewals, and Fresh Pipeline Catalysts

Zai Lab Limited Stock (NASDAQ: ZLAB) Today: Pre‑Market Watchlist After China’s COBENFY Approval, NRDL Renewals, and Fresh Pipeline Catalysts

Zai Lab shares were indicated around $18.58 premarket Friday, valuing the company near $2.1 billion. China approved COBENFY for schizophrenia on December 23, adding to recent company catalysts. U.S. markets reopen for a full session after the Christmas holiday, with thin liquidity and wider spreads expected. ZLAB’s 52-week range spans $16.82 to $44.34, with momentum indicators near oversold levels.
26 December 2025
···
Tesla Stock (TSLA) After the Bell Today 26.12.2025: NHTSA Model 3 Door Probe, Robotaxi Deadline Buzz, and What to Watch Before the Next Market Open

Tesla Stock (TSLA) After the Bell Today 26.12.2025: NHTSA Model 3 Door Probe, Robotaxi Deadline Buzz, and What to Watch Before the Next Market Open

U.S. regulators have opened a defect investigation into the 2022 Tesla Model 3, focusing on the accessibility of emergency door releases. Tesla shares traded slightly higher Friday near $486 in thin post-holiday volume, as investors weighed regulatory scrutiny against optimism over the company’s autonomy and AI roadmap. The regular session was still underway as of press time.
26 December 2025
··
Edgewise Therapeutics (EWTX) Stock Surges on EDG-7500 Safety Update as Wall Street Prepares to Reopen After Christmas

Edgewise Therapeutics (EWTX) Stock Surges on EDG-7500 Safety Update as Wall Street Prepares to Reopen After Christmas

Edgewise Therapeutics shares closed at $27.38 on December 24, up 26% after the company reported a favorable interim safety update for its EDG-7500 therapy in hypertrophic cardiomyopathy. Pre-market trading showed the stock at $27.46 as of 8:52 a.m. ET Friday. No clinically meaningful drops in ejection fraction or new atrial fibrillation were seen in the latest trial cohort. Regular U.S. trading resumes at 9:30 a.m. ET.
26 December 2025
···
Oracle Stock Heads for Worst Quarter Since 2001 as AI Spending Fears Collide With OpenAI, TikTok, and Hollywood Bets

Oracle Stock Heads for Worst Quarter Since 2001 as AI Spending Fears Collide With OpenAI, TikTok, and Hollywood Bets

Oracle (NYSE: ORCL) is closing out 2025 with the kind of volatility normally reserved for pure-play AI startups, not a 47-year-old enterprise software heavyweight. Shares are down about 30% so far this quarter, putting the stock on pace for its steepest quarterly decline since 2001, according to market reporting that tracked the move against Oracle’s early-2000s drawdowns. StockAnalysis The selloff has been fueled by a single, recurring question: Can Oracle finance—and execute—an AI data-center buildout big enough to meet demand without crushing its cash flow and balance sheet? That concern has only intensified as Oracle’s ambitions expand beyond the cloud.
26 December 2025
···
Polestar Stock (PSNY) News Today: Fresh Funding, Reverse Split Fallout, and What Investors Should Watch Before the Dec. 26 Open

Polestar Stock (PSNY) News Today: Fresh Funding, Reverse Split Fallout, and What Investors Should Watch Before the Dec. 26 Open

Polestar Automotive (PSNY) entered Friday’s premarket session indicated near $17.18, with investors watching a $300 million equity raise and a $300 million debt-to-equity conversion backed by Geely. U.S. stock markets had not yet opened at 9:00 a.m. ET after a holiday-shortened week, with trading volumes expected to be thin and index futures near flat.
26 December 2025
·
Applied Digital (APLD) Stock News, Forecasts and Analysis for Dec. 26, 2025: Macquarie Financing, Hyperscaler Deals, and What Comes Next

Applied Digital (APLD) Stock News, Forecasts and Analysis for Dec. 26, 2025: Macquarie Financing, Hyperscaler Deals, and What Comes Next

Applied Digital shares traded at $25.72 on Dec. 26, 2025, with a $7.18 billion market cap after sharp swings tied to new Macquarie-backed financing. The company disclosed a $100 million loan facility for AI data center development, with $45 million funded at closing and an 8% interest rate. SEC filings detailed terms and risks, fueling debate over financing costs and execution.
26 December 2025
·
1 … 623 624 625 626 627 … 1,177

Stock Market Today

Tower Semiconductor stock jumps again on Nvidia optics tie-up as earnings near

Tower Semiconductor stock jumps again on Nvidia optics tie-up as earnings near

8 February 2026
Tower Semiconductor shares rose 7.7% to $139.04 Friday after announcing a collaboration with Nvidia on AI data-center networking. The stock touched $141 intraday and gained another 1% after hours. Investors await Tower’s Feb. 11 earnings for details on its silicon photonics work. No financial terms or shipment timeline were disclosed.
Longsys Electronics stock heads into Monday after new guarantees; what 301308 investors watch next

Longsys Electronics stock heads into Monday after new guarantees; what 301308 investors watch next

8 February 2026
Longsys disclosed new guarantees for a 100 million yuan Hong Kong loan and a $9 million Brazil credit line, bringing its total approved guarantee quota to 11 billion yuan and outstanding guarantees to 5.81 billion yuan. The company said all guarantees are for consolidated subsidiaries and within approved limits. Shares closed at 288 yuan Friday, down 1.6%. China inflation and credit data are due this week.
MACOM stock price steadies near highs into Monday after earnings pop and fresh filings

MACOM stock price steadies near highs into Monday after earnings pop and fresh filings

8 February 2026
MACOM shares rose 3.5% to $235.87 Friday after the company reported fiscal Q1 revenue of $271.6 million and raised its full-year data center growth outlook to 35–40%. Fidelity’s FMR LLC disclosed a 10.7% stake, while shareholder Susan Ocampo filed to potentially sell up to 100,000 shares. Stifel raised its price target to $255. MACOM expects to repay $161 million in convertible notes in March.
Go toTop